Dongyan Zhang
Guangzhou, 510515, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
SLC1A5 overexpression accelerates progression of hepatocellular carcinoma by promoting M2 polarization of macrophages
Journal: Nan fang yi ke da xue xue bao = Journal of Southern Medical University
Published: March 03, 2025
Targeting NAD+ metabolism of hepatocellular carcinoma cells by lenvatinib promotes M2 macrophages reverse polarization, suppressing the HCC progression.
Journal: Hepatology international
Published: January 30, 2023
UBE2T-mediated Akt ubiquitination and Akt/β-catenin activation promotes hepatocellular carcinoma development by increasing pyrimidine metabolism.
Journal: Cell death & disease
Published: March 12, 2021
HRG switches TNFR1-mediated cell survival to apoptosis in Hepatocellular Carcinoma.
Journal: Theranostics
Published: April 22, 2020
Up-regulation of LncRNA SNHG20 Predicts Poor Prognosis in Hepatocellular Carcinoma.
Journal: Journal of Cancer
Published: September 11, 2015
miR-128a is up-regulated in hepatocellular carcinoma and promotes tumor cell proliferation by targeting RND3
Journal: Nan fang yi ke da xue xue bao = Journal of Southern Medical University
Published: October 28, 2014
The long intergenic noncoding RNA UFC1, a target of MicroRNA 34a, interacts with the mRNA stabilizing protein HuR to increase levels of β-catenin in HCC cells.
Journal: Gastroenterology
Published: May 22, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026